Evidence map›Paper›PMID 34029833›Full record

ArticleJournal of psychiatric research2021

Impact of COVID-19 lockdown on individuals under treatment for substance use disorders: Risk factors for adverse mental health outcomes.

C Blithikioti, L Nuño, B Paniello, A Gual, L Miquel

Open access · greenAbstract read
In one paragraph

Article in Journal of psychiatric research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 6 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 6 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. A Structural Validation of the Brief COPE Scale among Outpatients with Alcohol and Opioid Use Disorders.International journal of environmental research and public health · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

C BlithikiotiFaculty of Medicine, University of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, IDIBAPS, Barcelona, Spain; Grup de Recerca en addiccions clinic. GRAC, Institut clinic de Neurosciències, Barcelona, Spain.
L NuñoInstitut d'Investigacions Biomèdiques August Pi i Sunyer, IDIBAPS, Barcelona, Spain; Grup de Recerca en addiccions clinic. GRAC, Institut clinic de Neurosciències, Barcelona, Spain.
B PanielloGrup de Recerca en addiccions clinic. GRAC, Institut clinic de Neurosciències, Barcelona, Spain; FundacióClínic per la RecercaBiomèdica, FCRB, Barcelona, Spain.
A GualFaculty of Medicine, University of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, IDIBAPS, Barcelona, Spain; Grup de Recerca en addiccions clinic. GRAC, Institut clinic de Neurosciències, Barcelona, Spain.
L MiquelInstitut d'Investigacions Biomèdiques August Pi i Sunyer, IDIBAPS, Barcelona, Spain; Grup de Recerca en addiccions clinic. GRAC, Institut clinic de Neurosciències, Barcelona, Spain. Electronic address: MIQUEL@clinic.cat.
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESUniversitat de Barcelona · ESFundació Clínic per a la Recerca Biomèdica · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndividuals with Substance Use Disorders (SUD), are vulnerable to the psychological consequences of the COVID-19 pandemic. This is the first study to assess risk factors of adverse mental health outcomes during lockdown in a SUD population.

methodsThis was a cross-sectional study, conducted through an online survey that was completed by 303 individuals with SUD, attended in the Addiction Unit of University of Barcelona Clínic Hospital. Sociodemographic and clinical data were collected and descriptive analyses were carried out. Depending on whether individuals reported a worsening or no change/improvement in anxiety and depression symptoms during lockdown, the sample was divided in two groups. A logistic regression was then carried out to identify risk factors associated with adverse mental health outcomes.

resultsOverall, frequency of use for the majority of individuals with SUD remained stable during lockdown in comparison to the pre-lockdown era, although a reduction was found in frequency of tobacco, alcohol, cannabis and cocaine use in a small fraction of individuals with SUD. Symptoms of clinical anxiety were found in 58.7% of the sample while 48.2% of participants scored above the clinical threshold for depression. In addition, 50.3% of the sample reported a deterioration in depression and anxiety symptoms during lockdown that was associated with the following risk factors: previous trauma-exposure, female gender, distress and isolation, income reduction and alcohol use.

conclusionA high percentage of patients with SUD experienced adverse mental health outcomes during lockdown that were associated with several risk factors, which should be taken into account in policy making and prevention strategies, as well as in clinical practice, in order to provide personalized care to SUD patients during the time of the pandemic.

Indexed as

COVID-19Substance-Related DisordersAnxietyCommunicable Disease ControlCross-Sectional StudiesDepressionFemaleHumansMental HealthOutcome Assessment, Health CarePandemicsRisk FactorsSARS-CoV-2COVID-19LockdownMental healthRisk factorsSubstance use

Identifiers

PMID34029833
PMCPMC8769683
OpenAlexW3162399605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.